UBS Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154M | Buy |
293,515
+6,352
| +2% | +$3.33M | 0.03% | 550 |
|
|
2025
Q1 | $182M | Sell |
287,163
-95,672
| -25% | -$60.7M | 0.03% | 459 |
|
|
2024
Q4 | $273M | Buy |
382,835
+110,985
| +41% | +$79.1M | 0.05% | 302 |
|
|
2024
Q3 | $286M | Buy |
271,850
+17,389
| +7% | +$18.3M | 0.06% | 231 |
|
|
2024
Q2 | $267M | Sell |
254,461
-3,020
| -1% | -$3.17M | 0.07% | 225 |
|
|
2024
Q1 | $248M | Buy |
257,481
+122,544
| +91% | +$118M | 0.06% | 235 |
|
|
2023
Q4 | $119M | Buy |
134,937
+30,517
| +29% | +$26.8M | 0.04% | 370 |
|
|
2023
Q3 | $85.9M | Sell |
104,420
-56,022
| -35% | -$46.1M | 0.03% | 417 |
|
|
2023
Q2 | $115M | Buy |
160,442
+58,598
| +58% | +$42.1M | 0.04% | 346 |
|
|
2023
Q1 | $83.7M | Sell |
101,844
-37,451
| -27% | -$30.8M | 0.03% | 414 |
|
|
2022
Q4 | $100M | Buy |
139,295
+88,154
| +172% | +$63.6M | 0.04% | 367 |
|
|
2022
Q3 | $35.2M | Sell |
51,141
-73,182
| -59% | -$50.4M | 0.02% | 662 |
|
|
2022
Q2 | $73.5M | Buy |
124,323
+18,975
| +18% | +$11.2M | 0.03% | 419 |
|
|
2022
Q1 | $73.6M | Sell |
105,348
-83,823
| -44% | -$58.5M | 0.02% | 474 |
|
|
2021
Q4 | $119M | Sell |
189,171
-16,706
| -8% | -$10.6M | 0.03% | 370 |
|
|
2021
Q3 | $125M | Buy |
205,877
+48,150
| +31% | +$29.1M | 0.04% | 357 |
|
|
2021
Q2 | $88.1M | Sell |
157,727
-760
| -0.5% | -$424K | 0.03% | 438 |
|
|
2021
Q1 | $75M | Buy |
158,487
+18,922
| +14% | +$8.95M | 0.02% | 473 |
|
|
2020
Q4 | $67.4M | Buy |
139,565
+57,996
| +71% | +$28M | 0.02% | 486 |
|
|
2020
Q3 | $45.7M | Sell |
81,569
-45,315
| -36% | -$25.4M | 0.02% | 542 |
|
|
2020
Q2 | $79.1M | Buy |
126,884
+30,814
| +32% | +$19.2M | 0.03% | 341 |
|
|
2020
Q1 | $46.9M | Sell |
96,070
-24,372
| -20% | -$11.9M | 0.02% | 445 |
|
|
2019
Q4 | $45.2M | Sell |
120,442
-20,670
| -15% | -$7.76M | 0.02% | 641 |
|
|
2019
Q3 | $39.1M | Buy |
141,112
+33,692
| +31% | +$9.35M | 0.02% | 649 |
|
|
2019
Q2 | $33.6M | Sell |
107,420
-65,499
| -38% | -$20.5M | 0.01% | 721 |
|
|
2019
Q1 | $71M | Buy |
172,919
+67,585
| +64% | +$27.8M | 0.03% | 403 |
|
|
2018
Q4 | $39.3M | Sell |
105,334
-16,215
| -13% | -$6.06M | 0.02% | 551 |
|
|
2018
Q3 | $49.1M | Buy |
121,549
+23,021
| +23% | +$9.3M | 0.02% | 535 |
|
|
2018
Q2 | $34M | Buy |
98,528
+12,366
| +14% | +$4.27M | 0.01% | 671 |
|
|
2018
Q1 | $29.7M | Sell |
86,162
-50,582
| -37% | -$17.4M | 0.01% | 708 |
|
|
2017
Q4 | $51.4M | Buy |
136,744
+43,872
| +47% | +$16.5M | 0.02% | 491 |
|
|
2017
Q3 | $41.5M | Buy |
92,872
+29,959
| +48% | +$13.4M | 0.02% | 534 |
|
|
2017
Q2 | $30.9M | Buy |
62,913
+7,454
| +13% | +$3.66M | 0.02% | 626 |
|
|
2017
Q1 | $21.5M | Buy |
55,459
+14,550
| +36% | +$5.64M | 0.01% | 779 |
|
|
2016
Q4 | $15M | Buy |
40,909
+3,082
| +8% | +$1.13M | 0.01% | 900 |
|
|
2016
Q3 | $15.2M | Buy |
37,827
+5,918
| +19% | +$2.38M | 0.01% | 873 |
|
|
2016
Q2 | $11.1M | Buy |
31,909
+2,281
| +8% | +$797K | 0.01% | 996 |
|
|
2016
Q1 | $10.7M | Sell |
29,628
-41,694
| -58% | -$15M | 0.01% | 1006 |
|
|
2015
Q4 | $38.7M | Buy |
71,322
+17,101
| +32% | +$9.28M | 0.03% | 490 |
|
|
2015
Q3 | $25.2M | Sell |
54,221
-27,399
| -34% | -$12.7M | 0.02% | 597 |
|
|
2015
Q2 | $41.6M | Sell |
81,620
-6,372
| -7% | -$3.25M | 0.03% | 475 |
|
|
2015
Q1 | $39.7M | Sell |
87,992
-10,512
| -11% | -$4.75M | 0.03% | 491 |
|
|
2014
Q4 | $40.4M | Buy |
+98,504
| New | +$40.4M | 0.03% | 498 |
|